NORTHFIELD, Ill., Mar. 23, 2023—The College of American Pathologists (CAP), has introduced a new monkeypox (mpox) virus proficiency testing (PT) program for laboratories within the United States that will ship to customers in early summer.
The new mpox PT program will allow laboratories to add a level of quality assurance to molecular testing to ensure laboratories deliver accurate, reliable test results to detect mpox virus. Built upon a foundation of pathologist expertise, this program enables laboratories to achieve high standards of performance. It is the latest addition to the CAP’s comprehensive range of more than 700 programs across 16 disciplines developed by expert scientific committees. As laboratory medicine changes and adapts, so does the CAP, by continuing to support laboratories with new PT offerings that work across multiple platforms and across multiple methodologies.
CAP PT programs provide accurate and reliable test results. They draw some of the largest peer groups in the industry, enabling laboratories to compare their performance against a statistically significant data set.
About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, visit the CAP Newsroom, CAP.org and yourpathologist.org to watch pathologists at work and see the stories of the patients who trust them with their care.
###